Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 04.01.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
04.01.Sigyn Therapeutics, Inc.: Sigyn Therapeutics Releases Letter to Shareholders638SAN DIEGO, CA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a development-stage medical technology company, today announced...
► Artikel lesen
04.01.Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results322SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today...
► Artikel lesen
04.01.Pacira BioSciences: Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues591TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
► Artikel lesen
04.01.Telix Pharmaceuticals Limited: Telix Announces Planned Registered Public Offering and Listing in the United States296MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX, "Telix" or the "Company") today announces that it is considering an initial public offering ("IPO")...
► Artikel lesen
04.01.Axogen, Inc.: Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023418ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries...
► Artikel lesen
04.01.Eledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook514Reported updated data from ongoing Phase 1b trial in kidney transplantation demonstrating tegoprubart treatment successfully prevented kidney transplant rejection and was generally safe and well-tolerated...
► Artikel lesen
04.01.Axogen, Inc.: Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025322ALACHUA and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
► Artikel lesen
04.01.REVIV3 Procare Company Reports Record Second Quarter Fiscal Year 2024 Financial Results411Net Sales (revenue) increased 25.1% to a record $8.4 million for the second quarter ended November 30, 2023, as compared to the prior year period.Gross Profit (as a percentage of Net Sales) was 74.3%...
► Artikel lesen
04.01.Kernel Group Holdings, Inc. Confirms Funding to Extend Period to Consummate Initial Business Combination89New York, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) ("KRNL" or the "Company"), a special purpose acquisition company, announced today it caused to...
► Artikel lesen
04.01.Controladora Vuela Compañía de Aviación, S.A.B. de C.V.: Volaris Reports December 2023 Traffic Results: 85% Load Factor300MEXICO CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) ("Volaris" or "the Company"), the ultra-low-cost carrier (ULCC) serving...
► Artikel lesen
04.01.Asensus Surgical, Inc.: Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System1.830RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the...
► Artikel lesen
04.01.Costco Wholesale Corporation Reports December Sales Results200ISSAQUAH, Wash., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation ("Costco" or the "Company") (Nasdaq: COST) today reported net sales of $26.15 billion for the retail month of December...
► Artikel lesen
04.01.Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lympho579Partnership Will Utilize Foresight's Ultra-Sensitive MRD Technology to Identify Patients for Enrollment in Allogene's ALPHA3 Trial SAN FRANCISCO and BOULDER, Colo., Jan. 04, 2024 (GLOBE NEWSWIRE) --...
► Artikel lesen
04.01.Candelaria Mining Corp.: Candelaria Announces Change in Chief Financial Officer237VANCOUVER, British Columbia, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Candelaria Mining Corp. (TSX-V: CAND, OTC PINK: CDELF) (the "Company") announces, effective January 1, 2024, Mr. Sam Wong has resigned...
► Artikel lesen
04.01.CTO Realty Growth, Inc.: CTO Realty Growth Announces 2023 Transaction and Leasing Activity and Provides Share Repurchase Update372WINTER PARK, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO) (the "Company" or "CTO") today announced its 2023 investment, disposition and leasing activities and provided...
► Artikel lesen
04.01.Alpine Income Property Trust Announces 2023 Transaction Activity and Provides Corporate Update137WINTER PARK, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the "Company") today announced its 2023 investment and disposition activities and provided a corporate...
► Artikel lesen
04.01.Lumos Pharma, Inc.: Lumos Pharma Promotes Pisit "Duke" Pitukcheewanont, MD to Chief Medical Officer241AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, has promoted Pisit "Duke" Pitukcheewanont...
► Artikel lesen
04.01.Werewolf Therapeutics, Inc.: Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors242WATERTOWN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of...
► Artikel lesen
04.01.Mineralys Therapeutics, Inc.: Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer249RADNOR, Pa., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic...
► Artikel lesen
04.01.Allogene Therapeutics, Inc.: Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma237Four Core Programs Leverage Unique Attributes in Product Development and Trial Design to Demonstrate the Unmatched Potential of an Allogeneic CAR T Large B-Cell Lymphoma (LBCL): Groundbreaking ALPHA3...
► Artikel lesen
Seite:  Weiter >>